78th UNGA High-Level Meeting: Kenya's Commitment in the Fight Against Tuberculosis

New York , 22th September 2023 - During the 78th UNGA High-Level Meeting on the Fight Against Tuberculosis, held on September 22nd, 2023, in New York, CS Nakhumicha represented President William Ruto and articulated Kenya's unwavering commitment to global TB commitments. 

 

In 2022, Kenya reported 90,841 TB cases, marking a remarkable 42% reduction in TB mortality, surpassing global targets.

Kenya's commitment to eradicating TB as a public health threat transcends statistics.

 

The CS said the nation has increased domestic funding for TB control, resulting in improved access to high-quality TB services at all healthcare levels. This aligns closely with Kenya’s dedication to universal health coverage and sustainability. 

 

“With the impending launch of primary healthcare networks nationwide, Kenya aims to bolster efforts to reach TB clients in their homes and ensure treatment adherence,”

she added. 

 

Kenya is also forging synergies in its TB response through integrated healthcare, accelerating diagnosis, treatment, and prevention at all levels. 

 

Innovative approaches, such as tuberculosis self-screening, smart TB biometric systems, and Automated Tuberculosis Screening Machines, have connected individuals to diagnosis and treatment services. 

 

“Research and innovation remain pivotal in Kenya's efforts. Our country has introduced child-friendly TB medicines, rapid diagnostic tests, and digital technologies,” she noted. 

 

Kenya is also making substantial contributions to TB vaccine research through the Kenya Medical Research Institute (KEMRI), focusing on vaccines for both infants and adults. 

 

“In this critical juncture of our fight against TB, Kenya invites countries to unite behind WHO's Flagship Initiative to end TB,” Nakhumicha urged. 

 

Earlier this week, Kenya proudly joined other nations in launching the STOP TB Coalition of Leaders to End TB.

To enhance the quality of care, Kenya is committed to robust investments in research and development for innovative treatments, diagnostics, and vaccines. The nation also addresses the root causes of this epidemic, including poverty, undernutrition, and comorbidities like HIV, diabetes, and substance abuse.